Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Dissolving or eluting from solid or gel matrix
Reexamination Certificate
2006-04-25
2006-04-25
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Dissolving or eluting from solid or gel matrix
C424S001110, C424S400000, C424S422000, C424S001290
Reexamination Certificate
active
07033571
ABSTRACT:
A polymeric solution capable of gelling upon exposure to a critical minimum value of a plurality of environmental stimuli is disclosed. The polymeric solution may be an aqueous solution utilized in vivo and capable of having the gelation reversed if at least one of the stimuli fall below, or outside the range of, the critical minimum value. The aqueous polymeric solution can be used either in industrial or pharmaceutical environments. In the medical environment, the aqueous polymeric solution is provided with either a chemical or radioisotopic therapeutic agent for delivery to a specific body part. The primary advantage of the process is that exposure to one environmental stimuli alone will not cause gelation, thereby enabling the therapeutic agent to be conducted through the body for relatively long distances without gelation occurring.
REFERENCES:
patent: 4732930 (1988-03-01), Tanaka et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5252318 (1993-10-01), Joshi et al.
patent: 5256765 (1993-10-01), Leong
patent: 5410016 (1995-04-01), Hubbell et al.
patent: 5514379 (1996-05-01), Weissleder et al.
patent: 5525334 (1996-06-01), Ito et al.
patent: 5575815 (1996-11-01), Slepian et al.
patent: 5580929 (1996-12-01), Tanaka et al.
patent: 5589568 (1996-12-01), Higashijima et al.
patent: 5624685 (1997-04-01), Takahashi et al.
patent: 5634946 (1997-06-01), Slepian
patent: 5643246 (1997-07-01), Leeb et al.
patent: 5662609 (1997-09-01), Slepian
patent: 5674287 (1997-10-01), Slepian et al.
patent: 5695480 (1997-12-01), Evans et al.
patent: 5702361 (1997-12-01), Evans et al.
patent: 5749915 (1998-05-01), Slepian
patent: 5749922 (1998-05-01), Slepian et al.
patent: 5752974 (1998-05-01), Rhee et al.
patent: 5766704 (1998-06-01), Allen et al.
patent: 5830207 (1998-11-01), Leeb et al.
patent: 5843156 (1998-12-01), Slepian et al.
patent: 5843331 (1998-12-01), Schober et al.
patent: 5858746 (1999-01-01), Hubbell et al.
patent: 5876741 (1999-03-01), Ron
patent: 5939485 (1999-08-01), Bromberg et al.
patent: 5942209 (1999-08-01), Leavitt et al.
patent: 5954706 (1999-09-01), Sahatjian
patent: 5976648 (1999-11-01), Li et al.
patent: 5985384 (1999-11-01), Shibata
patent: 5998588 (1999-12-01), Hoffman et al.
patent: 6030442 (2000-02-01), Kabra et al.
patent: 6030634 (2000-02-01), Wu et al.
patent: 6090911 (2000-07-01), Petka et al.
patent: 6113629 (2000-09-01), Ken
patent: 6290729 (2001-09-01), Slepian et al.
patent: 6352682 (2002-03-01), Leavitt et al.
patent: 6443941 (2002-09-01), Slepian et al.
patent: 6652883 (2003-11-01), Goupil et al.
patent: 6660247 (2003-12-01), Gutowska et al.
patent: 2002/0168319 (2002-11-01), Filler et al.
patent: 0 704217 (1996-04-01), None
patent: 730 871 (1996-09-01), None
patent: 09154573 (1997-06-01), None
patent: 89/07117 (1989-08-01), None
patent: WO 91/19481 (1991-12-01), None
patent: WO 96/03112 (1996-02-01), None
patent: WO 97/33628 (1997-09-01), None
patent: WO 98/55147 (1998-12-01), None
patent: 99/49908 (1999-10-01), None
patent: WO 99/55386 (1999-11-01), None
patent: WO 99/56783 (1999-11-01), None
patent: 00/07603 (2000-02-01), None
patent: WO 00/43355 (2000-07-01), None
patent: WO 00/45868 (2000-08-01), None
Gutowska et al., “Thermosensitive Polymers for Drug Delivery,”American Chemical Society, vol. 37, No. 2, pp. 115-116 (1996).
Ganorkar et al., “Loading and Release Studies Using pH/Temperature-Sensitive Polymers for Oral Protein Delivery,”Proceed. Int'l. Symp. Control. Rel. Bioact. Mater., pp. 501-502 (1998).
Teramoto et al., “Phase transition for aqueous solution of polyelectrolyte complex containing N-isopropylamide,”Japanese Journal of Polymer Science and Technologyvol. 54, pp. 477-482 (1997) (Abstract).
Chen et al., “Graft Copolymers That Exhibit Temperature-Induced Phase Transitions Over a Wide Range of pH,”Nature, vol. 373, pp. 49-52 (1995).
Park, “Temperature Modulated Protein Release from pH/Temperature-Sensitive Hydrogels,”Biomaterials, vol. 20, pp. 517-521 (1999).
Zhang et al., “Synthesis and Characterization of pH- and Temperature-Sensitive Poly(methacrylic acid)/Poly(N-isopropylacrylamide) Interpenetrating Polymeric Networks,”Macromolecules, pp. A-F (1999).
Beltran et al., “Swelling Equilibria for Weakly Ionizable, Temperature-Sensitive Hydrogels,”Macromolecules, pp. 549-551 (1991).
Park et al., “Synthesis, Characterization, and Application of pH/Temperature Sensitive Hydrogels,”Proceed. Intern. Symp. Control. Rel. Bioact. Mater., pp. 112-113, 96 (1990).
Gutowska Anna
Krzyminski Karol J.
Battelle (Memorial Institute)
Jones Dameron L.
Klarquist & Sparkman, LLP
LandOfFree
Multiple stimulus reversible hydrogels does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multiple stimulus reversible hydrogels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multiple stimulus reversible hydrogels will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3613600